Oxford-AstraZeneca

AstraZeneca COVID Vaccine Linked With Small Risk of Low Blood Platelets: Study

Centre to Study Feasibility of Single Dose Covishield Regimen

Study Suggests Pfizer, Oxford Vaccines Reduce Severe COVID-19 in Elderly

Efficacy Data Lacking for India’s COVID Vaccines Against SARS-CoV-2 Variants

All Set for Roll-Out, Waiting for Vaccine to Arrive: Delhi Health Minister

Why AstraZeneca Is Facing Tricky Questions About Its COVID-19 Vaccine

Oxford Vaccine May Better Fit India Than Pfizer’s or Moderna’s: Gagandeep Kang